EKF Diagnostics Holdings plc (EKF) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to the EFK Diagnostics Holdings PLC investor presentation. Throughout this recorded presentation, investors will be in listen-only mode. Questions are encouraged and can be submitted at any time via the Q&A tab situated on the right-hand corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all questions submitted today and publish responses where it's appropriate to do so. Before we begin, I'd like to submit the following poll. And I'd now like to hand you over to Gavin Jones, CEO. Good morning, sir. Good morning. Thank you. And just to reiterate, that's EKF by Gnostic. This is our interim results for 2025. Thank you all for joining us today. Really appreciate it. I think I'll start with describing the team. Hopefully by now you know who I am. Joining me in the room is Stephen Young, our CFO. And slightly off camera is our Executive Chair, Julian Baines. You may hear him chip in every now and then. He can't help himself. But getting to the meat of the bones today, I think it's important to say that what we're going to be talking about is a fairly simple but significant update for the business. If you look at the revenues for the first half, we're at 25.2, which is very much in line with the same period. last year so you could say that it looks flat but if you look at it on a constant currency basis we're closer to 26 million if you also consider the fact that we've taken out some of the lower margin products that were causing us some challenges previously then actually it is we are delivering significant growth in the first half and we'll continue to do so into h2 You can see the impact of the re...